News Ethics and Policy Operational Efficiency Decision-Making Support Head and Neck Cancer

How Federal Regulatory Strategies Are Spurring Innovation in the Use of AI in Cancer Care

In an interview, Travis J. Osterman, DO, MS, FAMIA, FASCO, discusses current regulatory strategies surrounding the use and advancement of AI in oncology practice and the priorities of AI in cancer care for the next several years.

April 29, 2026 By Jo Cavallo 11 min read
Share

ASCO AI in Oncology is published by Conexiant under a license arrangement with the American Society of Clinical Oncology, Inc. (ASCO®). The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. For more information, see Policies.

KOL Commentary
Watch

Related Content